mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.005 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.006 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.006 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.007 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.007 |